Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
22.27
-0.28 (-1.24%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Perrigo Company Revenue
Perrigo Company had revenue of $1.06B in the quarter ending June 28, 2025, a decrease of -0.86%. This brings the company's revenue in the last twelve months to $4.33B, down -2.31% year-over-year. In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%.
Revenue (ttm)
$4.33B
Revenue Growth
-2.31%
P/S Ratio
0.71
Revenue / Employee
$516,303
Employees
8,379
Market Cap
3.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PRGO News
- 26 days ago - Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference - PRNewsWire
- 5 weeks ago - Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations - PRNewsWire
- 6 weeks ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 6 weeks ago - Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 7 weeks ago - Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025 - PRNewsWire
- 2 months ago - Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million - PRNewsWire
- 2 months ago - Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance - PRNewsWire